Retinoic Acid Receptor-β Gene Reexpression and Biological Activity in SHI-1 Cells after Combined Treatment with 5-Aza-2′-Deoxycytidine and All-Trans Retinoic Acid | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Retinoic Acid Receptor-β Gene Reexpression and Biological Activity in SHI-1 Cells after Combined Treatment with 5-Aza-2′-Deoxycytidine and All-Trans Retinoic Acid

Acta Haematol (2015) 133 (3): 279–286.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex

Lu Wang
Qi Zhang
Li Ye
Xingnong Ye
Wenli Yang
Hua Zhang
Xinping Zhou
Yanling Ren
Liya Ma
Xiang Zhang
Chen Mei
Gaixiang Xu
Kongfei Li
Yingwan Luo
Lingxu Jiang
Peipei Lin
Shuanghong Zhu
Wei Lang
Yuxia Wang
Chuying Shen
Yueyuan Han
Xiaozhen Liu
Haiyang Yang
Chenxi Lu
Jie Sun
Jie Jin
Hongyan Tong

British Journal of Cancer (2023) 128 (4): 691.

RARβ Expression in Keratinocytes from Potentially Malignant Oral Lesions: The Functional Consequences of Re-Expression by De-Methylating Agents

Raghu Radhakrishnan
Hannah L. Crane
Marc Daigneault
Kanaka Sai Ram Padam
Keith D. Hunter

Cancers (2021) 13 (16): 4064.

Decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia

Yan Lin
Rongrong Lin
Guangquan Zhou
Yue Liu
Weimin Dong
Yang Cao
Xiaobao Xie
Weiying Gu

Journal of International Medical Research (2019) 47 (2): 1064.

Enhanced expression of tumour suppressor RAR-β by DSPC nano-formulated lipo-ATRA in the lung of B16F10 cell-implanted C57BL6 mice and in A549 cells

V.M. Berlin Grace
Reshma Mahima Reji
Viswanathan Sundaram

Life Sciences (2017) 184: 10.

Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studies

Kelly J. Norsworthy
Eunpi Cho
Jyoti Arora
Jeanne Kowalski
Hua-Ling Tsai
Erica Warlick
Margaret Showel
Keith W. Pratz
Lesley A. Sutherland
Steven D. Gore
Anna Ferguson
Sarah Sakoian
Jackie Greer
Igor Espinoza-Delgado
Richard J. Jones
William H. Matsui
B. Douglas Smith

Leukemia Research (2016) 49: 90.

Low-dose decitabine plus all-trans retinoic acid in patients with myeloid neoplasms ineligible for intensive chemotherapy

Wei Wu
Yan Lin
Lili Xiang
Weimin Dong
Xiaoying Hua
Yun Ling
Haiqian Li
Feng Yan
Xiaobao Xie
Weiying Gu

Annals of Hematology (2016) 95 (7): 1051.